GlassScriptPhysician profile
Cameron Winfield Foreman
NPI 1770046799
$24,006.55
in general payments reported to CMS, 2019-2025
11 companies · $16K in 2025
The $16K reported for 2025 was more than what 80% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,559 · 2023: $203 · 2024: $4,907 · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $13K · Grant: $6,488 · Food and Beverage: $2,238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $12,721.91 |
| Grant | $6,487.95 |
| Food and Beverage | $2,237.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Uoc USA INC | $12,212.70 | 2025 | Uts, Conformity, U-Mii, U2 Revision Stem, Psa, Ustar, U2 Knee, Conformity, U-Motion II, U-Star II, U2 |
| Smith+Nephew, INC. | $5,045.73 | 2024-2025 | Pico 14 |
| Evolution Surgical, INC | $2,500.11 | 2022-2023 | |
| Stryker Corporation | $2,448.24 | 2022-2025 | Mako, Gamma, Accolade |
| Zimmer Biomet Holdings, INC. | $1,177.53 | 2024 | Arcos, Avenir, G7 |
| Depuy Synthes Sales INC. | $239.37 | 2024 | Attune |
| Medacta USA, INC. | $141.42 | 2024 | |
| Kci USA, INC. | $132.86 | 2023 | |
| Orthalign INC | $57.63 | 2024 | Orthalign Plus |
| Ermi LLC | $27.39 | 2025 | |
| Medical Device Business Services, INC. | $23.57 | 2024 | Stratafix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cameron Foreman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.